David A. DeGoey

<i>In Vitro</i> and <i>In Vivo</i> Antiviral Activity and Resistance Profile of Ombitasvir, an Inhibitor of Hepatitis C Virus NS5A

Preethi Krishnan, Jill Beyer, Neeta Mistry et al. · Antimicrobial Agents and Chemotherapy · 2014 · 130 citations · Full text

Discovery of ABT-267, a Pan-Genotypic Inhibitor of HCV NS5A

David A. DeGoey, John T. Randolph, Dachun Liu et al. · Journal of Medicinal Chemistry · 2014 · 126 citations

Excellent Potency, Medicinal Chemistry, Hcv Ns5a +11

Enantioselective Synthesis of Antiinfluenza Compound A-315675

David A. DeGoey, Hui-Ju Chen, William J. Flosi et al. · The Journal of Organic Chemistry · 2002 · 95 citations

Combinatorial Chemistry, Organic Chemistry, Chemistry +16

Beyond Rule of Five and PROTACs in Modern Drug Discovery: Polarity Reducers, Chameleonicity, and the Evolving Physicochemical Landscape

Edward Price, Manuel Weinheimer, Alexey Rivkin et al. · Journal of Medicinal Chemistry · 2024 · 62 citations

Pharmaceutical Science, Drug Target, Chemical Biology +19

Implications of the Conformationally Flexible, Macrocyclic Structure of the First-Generation, Direct-Acting Anti-Viral Paritaprevir on Its Solid Form Complexity and Chameleonic Behavior

Ahmad Y. Sheikh, Alessandra Mattei, Rajni M. Bhardwaj et al. · Journal of the American Chemical Society · 2021 · 50 citations